Literature DB >> 19459445

Influence of low doses of deoxynivalenol on histopathology of selected organs of pigs.

Ł Zielonka1, M Wiśniewska, M Gajecka, K Obremski, M Gajecki.   

Abstract

Deoxynivalenol is one of mycotoxins that are most frequently determined in animal feed manufactured in Poland. The examination of histopathological lesions concomitant with deoxynivalenol intoxication is difficult because of the common, often synergistic, reaction of this mycotoxin with other toxins, such as zearalenone or ochratoxin A, which has a strong nephrotoxic activity. The possibility of estimating histopathological lesions in the course of intoxication with pure toxin at various doses is therefore of interest. Dosages used in this experiment relate to clinical cases observed in feeding the animals with whole ration feed obtained by processing feedingstuffs contaminated with Fusarium moulds. However, concerning the fact of one-shot administration of clinically pure toxin, the main question was if it was a sufficient dose to cause changes in the histopathological picture of gastrointestinal tract organs. The experiment was carried out on 12 nursery pigs of mixed breed (Polish White Large x Polish White Ear-pendent) with an average body weigh of 35 kg. The experimental nursery pigs were divided into 3 groups: group I (n=4)--control; group II (n=4)--DON administered at a dose of 0.2 mg/kg b.w.; group III (n=4)--DON administered at a dose of 0.4 mg/kg b.w. After slaughter of the animals, macroscopic examination was performed and segments of duodenum, jejunum, ileum, liver and mesenteric lymph nodes were sampled and assigned for histopathological examination. The results obtained equate to the clinically observed signs in swine production involving some nutrient metabolism disturbances in the gastrointestinal tract in the course of deoxynivalenol mycotoxicosis. Histopathological examination of segments of the duodenum, the jejunum, the ileum, the liver and the lymph nodes indicate that the regressive lesions are more expressed in the experimental group treated with the highest concentration of deoxynivalenol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19459445

Source DB:  PubMed          Journal:  Pol J Vet Sci        ISSN: 1505-1773            Impact factor:   0.821


  6 in total

1.  Deoxynivalenol in the gastrointestinal tract of immature gilts under per os toxin application.

Authors:  Agnieszka Waśkiewicz; Monika Beszterda; Marian Kostecki; Łukasz Zielonka; Piotr Goliński; Maciej Gajęcki
Journal:  Toxins (Basel)       Date:  2014-03-05       Impact factor: 4.546

Review 2.  Effect of deoxynivalenol and other Type B trichothecenes on the intestine: a review.

Authors:  Philippe Pinton; Isabelle P Oswald
Journal:  Toxins (Basel)       Date:  2014-05-21       Impact factor: 4.546

3.  The Effect of Deoxynivalenol on Selected Populations of Immunocompetent Cells in Porcine Blood-A Preliminary Study.

Authors:  Michał Dąbrowski; Ewa Jakimiuk; Mirosław Baranowski; Magdalena Gajęcka; Łukasz Zielonka; Maciej Tadeusz Gajęcki
Journal:  Molecules       Date:  2017-04-26       Impact factor: 4.411

4.  In Vitro Assay of Translation Inhibition by Trichothecenes Using a Commercially Available System.

Authors:  Takahito Toyotome; Katsuhiko Kamei
Journal:  Toxins (Basel)       Date:  2021-10-01       Impact factor: 4.546

5.  Protective effect of a new generation of activated and purified bentonite in combination with yeast and phytogenic substances on mycotoxin challenge in pigs.

Authors:  Pavel Horky; Hana Abigail Gruberova; Tereza Aulichova; Svetlana Malyugina; Petr Slama; Ales Pavlik; Jiri Skladanka; Misa Skoric; Sylvie Skalickova
Journal:  PLoS One       Date:  2021-10-27       Impact factor: 3.240

6.  Deoxynivanelol and fumonisin, alone or in combination, induce changes on intestinal junction complexes and in E-cadherin expression.

Authors:  Karina Basso; Fernando Gomes; Ana Paula Loureiro Bracarense
Journal:  Toxins (Basel)       Date:  2013-11-28       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.